title: Comparison of calcium channel blocker and ACE inhibitor therapy on the progression of renal insufficiency.
authors.affiliation: Department of Nephrology, University of Modena, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Zucchelli
authors.forename: A
authors.initials: A
authors.lastname: Zuccalà
authors.forename: M
authors.initials: M
authors.lastname: Borghi
authors.forename: M
authors.initials: M
authors.lastname: Fusaroli
authors.forename: M
authors.initials: M
authors.lastname: Sasdelli
authors.forename: C
authors.initials: C
authors.lastname: Stallone
authors.forename: G
authors.initials: G
authors.lastname: Sanna
authors.forename: R
authors.initials: R
authors.lastname: Gaggi
authors.forename: E
authors.initials: E
authors.lastname: Degli Esposti
authors.forename: G
authors.initials: G
authors.lastname: Vendramin
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers